一个系统的免疫和预后分析CD48与瘤微环境的相互作用在泛癌症

Mingdong He1, Jun Yu1, Shaohua Chen2

  • 1Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.

概括

分化集群48 (CD48) 影响泛癌预后和免疫透. 评估CD48可能会改善患者的治疗结果和免疫治疗反应预测.